Skip to main content

Table 2 Summary of Genomic lesions occurring in plasmablastic lymphoma identified in the current study

From: Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma

Chromosome Cyto band Size, Mbp No. clones Freq, %
Gain     
1 1p36.11-1p36.33 8.3 10 44
  1p34.1-1p36.13 5.6 7 63
  1q21.1-1q23.1* 10.5 9 50
  1q42.1-1q43* 8 8 19
2 2p22-2p23* 0.7 3 13
  2p14-2p16* 2.7 3 13
3 3p14.3-3p21.32* 7.5 6 13
  3q26-3q26.3* 3 3 13
4 4p16.1-4p16.3 0.8 4 13
6 6p22-6p24.3* 9.9 11 13
7 7p21.3-7p23* 2.4 4 38
  7q11.2-7q11.22* 3.1 6 25
  7q11.2-7q11.23* 3.8 4 50
8 8p21.3-8p22 2.5 3 13
  8p12-8p12 1.5 3 13
  8q24.3-8qter 3.7 3 25
9 9q34.2-9q34.3* 2.2 4 13
10 10p12-10p12.33 2.9 3 23
  10q21.2-10q22.1 2.3 5 19
  11p12-11p13* 1 3 13
  11q12-11q13.2* 8.7 8 44
  11q13.4-11q14* 7.5 10 25
13 13q33.3-13q34* 1.1 4 13
14 14q21.1-14q21.3 3.2 4 13
  14q32.32-14q32.33 0.9 5 31
15 15q22-15q22 4.5 3 13
16 16p13.2-16p13.3* 4.6 8 38
  16p13.1-16p13.3* 8.6 11 19
  16p12-16p13.1* 8 5 25
  16p11.2-16p12.1* 7.1 5 13
  16q12.1-16q12.2 2.9 4 19
  16q21-16q22* 5.2 4 13
  16q24-16q24* 2.5 3 13
  16q24.1-16q24* 4.2 6 38
17 17p13-17p13.3* 2 8 38
  17p13.2-17p13.3* 5.3 9 31
  17q24-17q25.1* 3.1 6 19
19 19p13.12-19p13.3* 15.9 12 44
20 20q11.1-20q11.23 2.7 4 38
  20q12-20q13.3* 2.9 5 19
  20q13.2-20q13.33* 2 4 25
21 21q22.2-21q22.3* 5 3 13
22 22q11.1-22q11.22* 1.5 4 19
  22q12.2-22q13.3* 7.9 8 56
Loss     
1 1p36.11-1p36.33* 8.3 10 13
  1p31.2-1p33* 0.6 5 13
  1p31.1-1p32.1* 3.7 4 19
  1p22-1p31.2* 1.4 3 19
  1p13.3-1p22.3 0.5 3 13
  1q31.1-1q32.1 1.8 3 13
2 2q22-2q23.1* 2.4 3 13
  2q31-2q32.3 16.4 12 13
3 3p12-3p14.1 9.6 10 13
4 4q32.1-4q32.3* 11.7 9 13
5 5p14-5p14.3 4 6 23
6 6q16.2-6q16.2* 1.4 4 13
7 7q31-7q32.1 4.4 4 13
8 8q12.1-8q12.3 4.4 4 13
  8q24.2-8q24.3 3 4 13
10 10q24.31-10q26.13* 3.3 4 19
11 11q22-11q22.3 5.1 6 19
17 17p11.1-17p12* 5.2 6 13
18 18q11.2-18q12 3.1 3 13
  18q12-18q12.3 5.1 3 13
  18q22-18q22.1* 3 4 13
20 20p12.2-20p13 0.8 4 13
  20p12-20p12.2 2.2 7 19
  20p12-20p12.2 2.3 3 13
  20q13.11-20q13.33 5.1 5 13
  1. * Regions also reported to show gain or loss in diffuse large B-cell lymphoma by CHEN et al[19].